Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingzhikang is a traditional Chinese medicine product, most commonly recognized as a dietary supplement or health product rather than a conventional pharmaceutical drug. It is not to be confused with similarly named products such as "Qingkailing" or "QingyiHuaji." The name "Qingzhikang" is associated with Ganjiang New District Qingzhikang Pharmaceutical Technology Co., Ltd., which suggests it may be a proprietary formulation developed by this company[1]. While detailed composition and mechanism of action are not specified in the available sources, products under similar names in China are often marketed for cardiovascular health, lipid regulation, or general wellness. There is no evidence from the provided results that Qingzhikang refers to an approved pharmaceutical agent or that it has undergone clinical trials for specific diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingzhikang.